Brent Suen
Chief Executive Officer presso LOGIQ, INC.
Patrimonio netto: 998 177 $ in data 31/03/2024
Profilo
Brent Y.
Suen is the founder of Bay2peak S A (founded in 2003), Elevation Capital (founded in 1997), Axis Trading Corp.
(founded in 1993), and Logiq, Inc. (founded in 2014).
At Logiq, Inc., he holds the title of Executive Chairman, President & CEO.
Currently, Mr. Suen is the Chairman at GoLogiq, Inc. (since 2021).
In the past, he worked as the Director of Strategic Development at SinoBiomed, Inc. (from 2008 to 2011) and as a Director at Collective Audience, Inc. (from 2023 to 2024).
Mr. Suen obtained his undergraduate degree from The University of Arkansas.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
7.84% | 26/12/2023 | 1 079 578 ( 7.84% ) | 675 816 $ | 31/03/2024 |
GOLOGIQ, INC.
1.68% | 20/03/2023 | 1 061 703 ( 1.68% ) | 317 449 $ | 31/03/2024 |
LOGIQ, INC.
0.36% | 10/04/2023 | 377 842 ( 0.36% ) | 4 912 $ | 31/03/2024 |
Posizioni attive di Brent Suen
Società | Posizione | Inizio |
---|---|---|
LOGIQ, INC. | Chief Executive Officer | 07/01/2022 |
GOLOGIQ, INC. | Chairman | 26/11/2021 |
Precedenti posizioni note di Brent Suen
Società | Posizione | Fine |
---|---|---|
SinoBiomed, Inc.
SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Corporate Officer/Principal | 04/08/2011 |
Axis Trading Corp. | Founder | - |
Bay2peak S A | Founder | - |
Elevation Capital | Founder | - |
Formazione di Brent Suen
The University of Arkansas | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
LOGIQ, INC. | Technology Services |
GOLOGIQ, INC. | Technology Services |
Aziende private | 4 |
---|---|
SinoBiomed, Inc.
SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Health Technology |
Bay2peak S A | |
Elevation Capital | |
Axis Trading Corp. |
- Borsa valori
- Insiders
- Brent Suen